Dexmethylphenidate Production Cost Reports

The report provides a detailed analysis essential for establishing a dexmethylphenidate production plant. It encompasses all critical aspects necessary for dexmethylphenidate production, including the cost of dexmethylphenidate production, dexmethylphenidate plant cost, dexmethylphenidate production costs, and the overall dexmethylphenidate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a dexmethylphenidate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Dexmethylphenidate is a prescription medication mainly used for treating attention-related disorders. It is primarily utilised as a medication in the treatment of attention deficit hyperactivity disorder (ADHD) in both children and adults. It helps improve focus, attention, and control over impulsive behaviour by affecting certain chemicals in the brain. It is commonly formulated into tablets and extended-release capsules for daily therapeutic use. It is also prescribed to help manage symptoms of narcolepsy, which is a condition that causes sudden sleep attacks during the day. Moreover, it is used in clinical research to study neurological and behavioural conditions due to its stimulant properties. In addition, it is also used in the development of specialised treatments for managing cognitive and attention disorders.

The demand for dexmethylphenidate is primarily driven by its application as a prescription medication for supporting mental health and improving concentration, which boosts its market expansion. Its application in the treatment of attention deficit hyperactivity disorder (ADHD) also boosts its demand in the medical and healthcare sectors. Its application as an important drug for improving concentration and reducing hyperactivity in diagnosed individuals further contributes to its demand in the medical and pharmaceutical industries.

Its application in improving focus, attention span, and impulse control significantly promotes its market demand. Furthermore, the rising global awareness and diagnosis rates of ADHD, along with the increasing acceptance of stimulant-based therapies, are major factors that boost its demand. Industrial dexmethylphenidate procurement depends on factors such as the cost and secure availability of raw materials, regulatory frameworks across different regions, and the need for compliance with Good Manufacturing Practices (GMP). In addition, supplier consistency, evolving drug formulation technologies, and expanding mental health initiatives worldwide also have a direct impact on its procurement strategies and supply chain management.

Raw Material for Dexmethylphenidate Production

According to the dexmethylphenidate production plant project report, the major raw materials for dexmethylphenidate production include dl-threo-methylphenidate base, di-pivaloyl-D-tartaric acid, hydrochloric acid–isopropyl alcohol solution, and acetone.

Production Process of Dexmethylphenidate

The extensive dexmethylphenidate production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of dexmethylphenidate begins with the resolution of a racemic mixture of dl-threo-methylphenidate base using di-pivaloyl-D-tartaric acid in a suitable solvent. The reaction helps selectively form the dipivaloyl tartrate salt of the desired d-threo-methylphenidate. Then, this salt is treated with a base to release the optically pure d-threo-methylphenidate base, followed by extraction into an appropriate organic solvent. The purified base is further reacted with a hydrochloric acid–isopropyl alcohol solution, which leads to the formation of a slurry of dexmethylphenidate hydrochloride. Then, the final product is isolated by filtration and washing the resulting product with acetone to obtain optically pure dexmethylphenidate hydrochloride as the desired product.

Dexmethylphenidate is the dextrorotatory enantiomer of methylphenidate, and it acts as a central nervous system stimulant. It appears as a white to off-white crystalline powder. The molecular formula of the compound is C14H19NO2, and its molar mass is 233.31 g/mol. The hydrochloride salt of the compound is freely soluble in water and methanol, soluble in alcohol, and slightly soluble in chloroform and acetone. The compound functions as a norepinephrine-dopamine reuptake inhibitor and is primarily used for the treatment of attention deficit hyperactivity disorder. The melting point of the compound is greater than >203 degree Celsius. It is classified as a Schedule II controlled substance due to its high potential for abuse and dependence. Common adverse effects associated with the compound include decreased appetite, insomnia, headache, abdominal pain, and anxiety. It is recommended to use this medication only under medical supervision, as misuse can lead to serious cardiovascular effects, psychological disturbances, and the development of substance use disorder.